CRVS
Corvus Pharmaceuticals Inc.
$6.04
+$0.17(+2.90%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$437.40M
Volume
434.73K
52W Range
$2.54 - $10.00
Target Price
$14.80
EPS Estimates Overview
| Current Quarter | $-0.13 | Next Quarter | $-0.13 |
| Current Year | $-0.51 | Next Year | $-0.63 |
| QoQ Growth | +0.0% | YoY Growth | -23.5% |
| 3Y EPS CAGR | N/A | Target Price | $14.80 |
| Consensus | Buy | Upside | +145.0% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $6.04 | +2.9% | 434.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW